Immunology/Inflammation related Antibody
Anti-CD19 Antibody (Tafasitamab) is an Fc-engineered humanized monoclonal antibody that specifically targets the CD19 antigen on B lymphocytes. The compound mediates potent antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) by enhanced binding to Fcgamma receptors on effector cells, thereby directly inducing cell death and depleting malignant B cells. It serves as a pharmacological tool for investigating diffuse large B-cell lymphoma (DLBCL) and other B-cell malignancies.
Product Specifications
Target
Immunology/Inflammation related
Clonality
Monoclonal
Conjugation
Unconjugated
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Benzyl 2-isopropyl-4-oxotetrahydro-1 (2H) -pyridinecarboxylate
Vmn2r21 sgRNA CRISPR Lentivector (Mouse) (Target 2)
